皮康王品牌怎么样 申请店铺

我要投票 皮康王在保健药品行业中的票数:686 更新时间:2025-12-07
皮康王是哪个国家的品牌?「皮康王」是 拜耳医药保健有限公司 旗下著名品牌。该品牌发源于云南省昆明市,在1993年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力皮康王品牌出海!将品牌入驻外推网,定制皮康王品牌推广信息,可以显著提高皮康王产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

皮康王怎么样


“皮康王”最初由上海部队院校研制成功,具有神秘的军队血统。曾因帮助老山前线部队解决了因湿热环境引发的脚癣、体癣、股癣及皮肤瘙痒等问题,被誉为“皮疾克星”。后在国家政策放开的情况下由滇虹药业最早获得“军转民”的生产资格,于1993年隆重上市。

滇虹药业集团前身为中美合资昆明滇虹药业有限公司,系由滇虹天然药物厂与美国大东企业于1997年合资设立,承继1993年注册成立的滇虹天然药物厂的全部业务,设立至今始终由中方控股。2012年,昆明滇虹药业有限公司改制变更为滇虹药业集团股份有限公司。2014年3月,拜耳集团完成对滇虹药业集团公司所有股份的收购。滇虹药业集团公司正式成为拜耳集团子公司。

滇虹药业集团是一家研发导向型、集研发、生产和营销为一体的现代化制药企业集团。滇虹药业现有员工3000余名,营销网络覆盖全国乃至东南亚国家及非洲地区。作为云药产业发展的中坚力量,滇虹药业勇于创新、积极开拓,已成长为中国医药行业的知名企业。

通过持续的品牌建设,滇虹药业主品牌“康王”以其广泛的美誉度和影响力,经国家工商行政管理总局及最高人民法院联合认定为“中国驰名商标”,同时上榜“亚洲最具价值500强品牌”。集团旗下产品以质量可靠、疗效确切赢得众多患者青睐。其中包括被誉为“去屑专家”的“康王发用洗剂”以及被誉为“皮疾克星”的“皮康王”、妇科知名产品“丹莪妇康煎膏”等一批享誉国内外的品牌产品。

伴随企业社会知名度和美誉度的不断提升,公司正式确立了植根于品牌的“以消费者大健康产业为主体,以拓展医药及国际市场为两翼”的“一体两翼”消费者大健康产业发展战略。在这一战略指引下,滇虹药业积极推动中国负责任的自我保健及自我药疗事业进程,推动设立国际自我保健日。同时展开产业整合,打造中药标准化平台,集中优势资源将民族品牌做强做大。

滇虹药业被国家五部委联合认定为“国家级企业技术中心”,被云南省人民政府列为“省重点制药企业”,被中华全国工商联和国家税务总局评为“诚信纳税”企业,被全国总工会和中华全国工商联评为“双爱双评”先进企业。多次荣获国家有关部委、省市区各级政府表彰奖励,多次接待国家和国外领导人、省市领导的参观访问。

依托高质量的产品优势和良好的企业文化积淀,滇虹药业气势如虹,开疆拓土,在大健康产业领域以良好的发展态势傲视同侪。秉持“以人为本、艰苦奋斗、科技兴药”的企业理念,怀着“关注健康,造福人类”的企业追求,滇虹愿与社会各界人士携手,共襄医药产业美好未来。


"King Picon" was originally developed by Shanghai military academy, which has a mysterious military pedigree. He once helped Laoshan front-line army to solve the problems of tinea cruris, tinea corporis, tinea cruris and pruritus caused by humid and hot environment, which was known as "skin disease killer". After the opening of the national policy, Dian Hong pharmaceutical industry was the first to obtain the qualification of "military to civilian" production, which was solemnly listed in 1993. Yunnan Hong Pharmaceutical Group, formerly known as Sino US joint venture Kunming Yunnan Hong Pharmaceutical Co., Ltd., is a joint venture established by Yunnan Hong Natural Pharmaceutical Co., Ltd. and Dadong enterprise of the United States in 1997. It inherits all businesses of Yunnan Hong Natural Pharmaceutical Co., Ltd. registered in 1993 and has been controlled by China ever since its establishment. In 2012, the restructuring of Kunming Dianhong Pharmaceutical Co., Ltd. was changed to Dianhong Pharmaceutical Group Co., Ltd. In March 2014, Bayer Group completed the acquisition of all shares of Dianhong Pharmaceutical Group. Dianhong pharmaceutical group company has officially become a subsidiary of Bayer Group. Dianhong Pharmaceutical Group is a R & D-oriented, research and development, production and marketing as one of the modern pharmaceutical enterprise groups. Dianhong pharmaceutical has more than 3000 employees, and its marketing network covers the whole country, even Southeast Asian countries and Africa. As the backbone of the development of Yunnan pharmaceutical industry, Dianhong pharmaceutical industry has the courage to innovate and actively explore, and has grown into a well-known enterprise in China's pharmaceutical industry. Through continuous brand building, the owner brand of Dianhong Pharmaceutical Co., Ltd. "Kangwang", with its extensive reputation and influence, was jointly recognized as "China's famous trademark" by the State Administration for Industry and Commerce and the Supreme People's court, and listed as "the most valuable 500 brands in Asia". The group's products have won the favor of many patients with reliable quality and exact curative effect. Among them, "Kangwang hair lotion" which is known as "Dandruff removal expert" and "picongwang" which is known as "pixixing" and "Dane Fukang Decoction", which is a famous gynecological product, are well-known brand products at home and abroad. With the continuous improvement of corporate social popularity and reputation, the company has officially established the "one body and two wings" development strategy of consumer health industry, which is rooted in the brand and takes the consumer health industry as the main body and the expansion of medicine and international market as the two wings. Under the guidance of this strategy, Dianhong pharmaceutical actively promotes China's responsible self-care and self medication career, and promotes the establishment of the international self care day. At the same time, we will carry out industrial integration, build a platform for standardization of traditional Chinese medicine, and focus on advantageous resources to strengthen and expand national brands. Dianhong pharmaceutical industry is jointly recognized as "national enterprise technology center" by five ministries and commissions of the state, as "provincial key pharmaceutical enterprise" by Yunnan Provincial People's government, as "honest tax payment" enterprise by all China Federation of industry and Commerce and State Administration of Taxation, and as "double love and double evaluation" advanced enterprise by all China Federation of trade unions and all China Federation of industry and commerce. It has won many awards from relevant national ministries and commissions, provincial and municipal governments at all levels, and received many visits from national and foreign leaders and provincial and municipal leaders. Relying on the advantages of high-quality products and good corporate culture accumulation, Dianhong pharmaceutical industry is in a great momentum, expanding its territory and dominating its peers in the field of big health industry with a good development momentum. Adhering to the enterprise philosophy of "people-oriented, hard work, science and technology to promote medicine" and the enterprise pursuit of "focusing on health and benefiting mankind", Dianhong is willing to work with people from all walks of life to share the bright future of medicine industry.

本文链接: https://brand.waitui.com/3539f7c8f.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

马斯克抨击欧盟对社交媒体平台X巨额罚款

美国企业家马斯克6日抨击欧盟针对其社交媒体平台X的1.2亿欧元罚款决定,称将对处罚决定相关的欧盟高级官员作出回应。 “欧盟不仅对X处以如此荒谬的罚款,还对我个人处以罚款,这简直太荒唐了!”马斯克在X上写道。“因此,我们不仅应该对欧盟,还应该对那些针对我采取这种行动的人作出回应。”他随后发帖称“欧盟应该被废除”。 据悉,美国政府谴责欧盟对社交媒体X公司处以罚款,认为此举特别针对美国公司。美国总统特朗普称,如果欧盟继续惩罚美国科技企业,美国将对欧盟加征关税。 欧盟委员会5日发布公报说,欧盟委员会当天根据《数字服务法案》作出首份“不合规决定”,对美国企业家马斯克旗下社交媒体平台X罚款1.2亿欧元。

2小时前

北京新房年末出现供应潮:海淀量最大,聚焦改善型,拿证即推盘

年末将至,北京住宅市场迎来供应集中放量。根据北京市住建委官网信息,2025年11月共核发12张普通住宅预售许可证,覆盖海淀、朝阳、通州等7个区域,累计释放房源超3000套,其中6个为首次入市项目,为市场注入新活力。从节奏看,11月27日成为关键节点,当日4个项目同步获批,单日释放1531套房源,占当月总供应量近五成,形成阶段性供应高峰。值得关注的是,迫于年末销售窗口期压力,房企普遍加快入市节奏,多个项目在取证次日便火速开盘,以期抢占市场份额。

2小时前

阿斯利康乳腺癌新药卡匹色替片纳入国家医保

从阿斯利康公司获悉,企业乳腺癌领域的创新药物荃科得®(通用名:卡匹色替片)纳入2025国家医保药品目录,主要治疗HR阳性晚期乳腺癌。卡匹色替于今年4月在中国获批。

2小时前

CME数据中心运营商承认操作违规 致上周交易中断

上周五,全球第二大衍生品交易所——芝商所(CME)旗下多个市场因数据中心故障中断交易超过10小时。数据中心运营商CyrusOne本周六证实,此次重大中断源于人为操作失误。CyrusOne发言人表示,位于伊利诺伊州奥罗拉的数据中心现场工作人员及承包商未按标准在冷冻天气前对冷却塔进行排水,导致冷却系统结冰超压运行,设备温度失控。尽管CyrusOne称已采取全面且果断措施恢复冷却系统,但CME在声明中指出,数据中心最初的补救措施反而加剧了问题,最终导致多台冷却器的故障。此次事件凸显了CME对单一数据中心的高度依赖风险。该设施原为CME所有,于2016年出售给CyrusOne,并签订为期15年的回租协议。CME这周六表示:我们充分认识到此次事件对全球客户造成的严重影响。

2小时前

俄副总理:准备迎接无限量印度工人

据“今日俄罗斯”(RT)当地时间12月6日报道,普京访印期间,俄印两国签署了劳动力流动协议。 当地时间12月5日,俄罗斯第一副总理丹尼斯·曼图罗夫(Denis Manturov)表示,俄罗斯已准备好接收“无限数量的”(an unlimited number)来自印度的技术工人,以帮助解决国内劳动力短缺问题。 他告诉塔斯社,俄罗斯制造业至少需要80万名额外工人,而贸易部门则面临约150万个职位空缺。他还补充说,服务业和建筑业也需要专业人才。“我认为我们有充足的合作空间。”他说道。 不过,曼图罗夫指出,进入俄罗斯的印度移民工人数量,“不会在一年内出现大幅增长”,因为这个过程“需要时间”。

2小时前

本页详细列出关于皮康王的品牌信息,含品牌所属公司介绍,皮康王所处行业的品牌地位及优势。
咨询